NCT04849676

Brief Summary

After incomplete spinal cord injury (iSCI), many people still have control over their upper and/or lower limbs, but secondary conditions such as spasticity impair the function they have left. Spasticity includes increased reflex response and muscle tone, and is often painful. In this study we want to test a rehabilitation therapy to reduce spasticity after iSCI and improve participants' control over their extremities. The study involves recording participants' brain signals (EEG) and displaying them on a computer, so that they learn to control specific features derived from their brain waves. This is called neurofeedback (NF). Two studies conducted in our group that explored NF effect on central neuropathic pain in iSCI reported as incidental finding a decrease in spasms, muscle tightness and foot drop. The effect of NF is immediate and lasts up to 24 hours. In this study, we will explore systematically the short- and medium-term effect of NF on a larger number of iSCI, to inform a potential randomized clinical trial. Gaining control over one's brain activity requires practice and 80-90% people eventually learn the skill. Each participant will therefore attend five sessions of NF taking no longer than two hours each. 20 participants will be recruited and assigned to either upper or lower limb spasticity groups. This will allow us to determine if the mechanism of NF differs between arms and legs. Participants will be further grouped into sub-acute and chronic groups, depending on the time since injury, to pinpoint at what stage post-injury NF is the most effective. All groups will receive the same number of NF sessions. The primary outcome of this study is the change in spasticity of the hand or leg, as measured by the Modified Ashworth Scale (MAS). Secondary outcomes include use of arm/leg, quality of life, and the relation between functional improvement and EEG changes. Outcomes will be compared before/after each session, and before/after the whole intervention period, both inter- and intra-group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

August 31, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

April 18, 2022

Status Verified

April 1, 2022

Enrollment Period

1.7 years

First QC Date

April 15, 2021

Last Update Submit

April 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Modified Ashworth Scale

    Improvements in spasticity in the upper or lower limb (UL, LL groups) after neurofeedback sessions

    4 weeks

Secondary Outcomes (3)

  • Functional improvements

    4 weeks

  • Participant experience

    1 hour; after the last experimental session

  • Correlation between EEG activity and functional improvements

    one day to one month after the last experimental session, off line quantitative analysis

Study Arms (4)

Upper limb subacute spinal cord injury (sUL)

EXPERIMENTAL

Intervention: neurofeedback. Participants will receive visual feedback on a screen. Diagnostic Tests: Modified Ashworth Scale grading muscle resistance to movement (all limbs tested) Perceived Spasticity level questionnaire on impact of spasticity Spinal Cord Independence Measure questionnaire on level of independence of patients Diary of spastic episodes Grip strength - measure of hand and forearm muscle strength using dynamometer Instrumented Pendulum test - oscillations when forearm is dropped from a resting position Hand grip - closing and opening the fist recorded with Kinect (Microsoft) device EEG recording in relaxed state with bioamplifier g.usbamp (Guger Technologies, Austria) Brief Visual Analog Scale self-assessment of performance and mental strategies Motor evoked potential - effect of therapy on the descending path from brain to spinal cord with a transcranial magnetic stimulator (200-2, Magstim Co Ltd)

Other: visual neurofeedback

Upper limb chronic spinal cord injury (sUL)

EXPERIMENTAL

Intervention: neurofeedback. Participants will receive visual feedback on a screen. Diagnostic Tests: Modified Ashworth Scale grading muscle resistance to movement (all limbs tested) Perceived Spasticity level questionnaire on impact of spasticity Spinal Cord Independence Measure questionnaire on level of independence of patients Diary of spastic episodes Grip strength - measure of hand and forearm muscle strength using dynamometer Instrumented Pendulum test - oscillations when forearm is dropped from a resting position Hand grip - closing and opening the fist recorded with Kinect (Microsoft) device EEG recording in relaxed state with bioamplifier g.usbamp (Guger Technologies, Austria) Brief Visual Analog Scale self-assessment of performance and mental strategies Motor evoked potential - effect of therapy on the descending path from brain to spinal cord with a transcranial magnetic stimulator (200-2, Magstim Co Ltd)

Other: visual neurofeedback

Lower limb subacute spinal cord injury (sLL)

EXPERIMENTAL

Intervention: neurofeedback. Participants will receive visual feedback on a screen. Diagnostic Tests: Modified Ashworth Scale grading muscle resistance to movement (all limbs tested) Perceived Spasticity level questionnaire on impact of spasticity Spinal Cord Independence Measure questionnaire on level of independence of patients Diary of spastic episodes Instrumented Pendulum test - oscillations when lower leg is dropped from a resting position 10m walking test - patient walks 10 meters in a straight line, recorded with Kinect (Microsoft) device EEG recording in relaxed state with bioamplifier g.usbamp (Guger Technologies, Austria) Brief Visual Analog Scale self-assessment of performance and mental strategies Motor evoked potential - effect of therapy on the descending path from brain to spinal cord with a transcranial magnetic stimulator (200-2, Magstim Co Ltd)

Other: visual neurofeedback

Lower limb chronic spinal cord injury (cLL)

EXPERIMENTAL

Intervention: neurofeedback. Participants will receive visual feedback on a screen. Diagnostic Tests: Modified Ashworth Scale grading muscle resistance to movement (all limbs tested) Perceived Spasticity level questionnaire on impact of spasticity Spinal Cord Independence Measure questionnaire on level of independence of patients Diary of spastic episodes Instrumented Pendulum test - oscillations when lower leg is dropped from a resting position 10m walking test - patient walks 10 meters in a straight line, recorded with Kinect (Microsoft) device EEG recording in relaxed state with bioamplifier g.usbamp (Guger Technologies, Austria) Brief Visual Analog Scale self-assessment of performance and mental strategies Motor evoked potential - effect of therapy on the descending path from brain to spinal cord with a transcranial magnetic stimulator (200-2, Magstim Co Ltd)

Other: visual neurofeedback

Interventions

Neurofeedback is a neuromodulatory intervention that does not require applying external stimuli. It relies on displaying participants' brain activity in real time, with the aim of modifying it. Electrical activity (EEG) will be recorded from participants and displayed in real time on a computer screen, in the form of three bars. They will be asked to increase the middle bar, while keeping the side bars low. The intervention requires training to achieve voluntary control of the targeted brain activity.

Lower limb chronic spinal cord injury (cLL)Lower limb subacute spinal cord injury (sLL)Upper limb chronic spinal cord injury (sUL)Upper limb subacute spinal cord injury (sUL)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged above 18
  • Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
  • Injury occurred no more than six months prior to participation in the study
  • Injury level C3 to C7
  • Normal or corrected to normal vision
  • Spasticity equivalent of MAS level 1+ and above
  • Aged above 18
  • Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
  • Injury occurred more than one year prior to participation in the study
  • Injury level C3 to C7
  • Normal or corrected to normal vision
  • Spasticity equivalent of MAS level 1+ and above
  • Live in Greater Glasgow and Clyde area
  • Aged above 18
  • Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
  • +13 more criteria

You may not qualify if:

  • Participation in any other neurofeedback intervention group
  • Inability to understand the task
  • Self-reported neurological disorders e.g. previously confirmed peripheral nerve injury or brain injury
  • General poor health due to secondary consequences of injury
  • Conditions contra-indicative of neurostimulator usage (implanted devices, sensitive skin sores in the upper and lower extremities, pregnancy, severe autonomic dysreflexia)
  • History of epilepsy
  • Inability to sit for 1.5 hours
  • Inability to speak and/or understand English
  • Participation in any other neurofeedback intervention group
  • Inability to understand the task
  • Self-reported neurological disorders e.g. previously confirmed peripheral nerve injury or brain injury
  • General poor health due to secondary consequences of injury
  • Conditions contra-indicative of neurostimulator usage (implanted devices, sensitive skin sores in the upper and lower extremities, pregnancy, severe autonomic dysreflexia)
  • History of epilepsy
  • Inability to sit for 1.5 hours
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth University Hospital, Queen Elizabeth National Spinal Injurie Unit

Glasgow, Glasgow City, G51 4TF, United Kingdom

RECRUITING

Study Officials

  • Mariel Purcell, MD

    NHS Greater Galsgow and Clyde

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2021

First Posted

April 19, 2021

Study Start

August 31, 2021

Primary Completion

May 1, 2023

Study Completion

July 1, 2023

Last Updated

April 18, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

Shared on request

Shared Documents
STUDY PROTOCOL
Time Frame
After study end (March 2023)
Access Criteria
Data will be shared upon reasonable request

Locations